The story of Viagra and its influence on the pharmaceutical landscape presents a thorny question for shareholders . Initially a blockbuster drug, copycat medications have significantly chipped away at its market dominance, creating difficulties for companies connected to the original patent holder and related formulas. While particular businesses m